Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A

Eitemau Tebyg

• Severe left ventricular hypertrophy in Anderson-Fabry disease
  gan: Bhatia, G S, et al.
  Cyhoeddwyd: (2004)
• Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and α-galactosidase A activity
  gan: Wu, Justina C., et al.
  Cyhoeddwyd: (2010)
• Methotrexate reduces antibody responses to recombinant human α-galactosidase A therapy in a mouse model of Fabry disease
  gan: GARMAN, R D, et al.
  Cyhoeddwyd: (2004)
• Recombinant Enzyme Therapy for Fabry Disease: Absence of Editing of Human α-Galactosidase A mRNA
  gan: Blom, Daniël, et al.
  Cyhoeddwyd: (2003)
• Efficient Uptake of Recombinant α-Galactosidase A Produced with a Gene-Manipulated Yeast by Fabry Mice Kidneys
  gan: Tsukimura, Takahiro, et al.
  Cyhoeddwyd: (2011)